Clinical Trials Logo

Clinical Trial Summary

This study is designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of multiple subcutaneous and/or intravenous doses of PF-06741086 in subjects with severe hemophilia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02974855
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 2
Start date March 8, 2017
Completion date December 3, 2018

See also
  Status Clinical Trial Phase
Completed NCT03363321 - PF-06741086 Long-term Treatment in Severe Hemophilia Phase 2